The distribution of hematoporphyrin derivative (HPD) in the rat 9L gliosarcoma intracerebral brain tumor model at 4, 24, 48, and 72 hours after intravenous administration was evaluated using a digital video fluorescence microscopy technique. Maximum tissue fluorescence in the normal brain was observ
Hematoporphyrin derivative photoradiation therapy
β Scribed by Michael W. Berns
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 175 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0196-8092
No coin nor oath required. For personal study only.
β¦ Synopsis
The idea of using hematoporphyrin or hematoporphyrin derivative (HPD) in combination with light as a diagnostic and/or therapeutic modality for human cancer dates back to published work in the early 1960s. Lipson and Baldes [l] described the photodynamic properties of a hematoporphyrin derivative in the Archives of Dermatology in 1960. The same group similarly published hematoporphyrin cancer papers in 1961 [2], and 1972 [3]. Kelly and Snell described the potential use of HPD for bladder cancer diagnosis and treatment in 1976 [4].
However, as most investigators in this field will agree, the major impetus for the further growth and development of HPD-photoradiation therapy (PRT) in the treatment of human cancer has come from the work of T. J.
π SIMILAR VOLUMES
## Abstract In a rabbit model, endometriotic lesions were utilized to study hematoporphyrin derivative (HPD) uptake and the effect of photoradiation using the gold vapor laser. Morphological studies confirmed successful induction of ectopic endometrial growth and the lesions displayed preferential
Kodak projectors with #2418 red Coming filters were used as a light source to treat cutaneous and subcutaneous malignancies in five patients who previously had been given hematoporphyrin derivative (HpD). An argon dye laser system was used to treat malignancies in patients who also were given the Hp
Photoradiation therapy (PRT) with administration of hematoporphyrin derivative (HPD) was performed in ten cases of early stage central-type lung cancer of which six cases were treated by PRT alone due to inoperability because of poor pulmonary function in five and refusal of surgery in one. Four cas
## Abstract Hematoporphyrin derivativeβphotoradiation therapy (HPDβPRT) of human malignancy has been performed on 267 tumor sites in 50 patients. Tumor response has been assayed at 24 hours and one month following treatment with 625β635 nm light from an argon laserβpumped dye laser. The majority of
Hematoporphyrin derivative-photoradiation therapy (HPD-PRT) was used to treat choroidal melanomas in 23 human subjects. Tumor sizes were divided into three categories: less than 500 mm3 (11 patients), 500-1,OOO mm3 (four patients), and greater than 1,OOO mm3 (eight patients). Tumors were exposed to